Intel tips 22-nm tri-gate, but mobile is MIA
Mark LaPedus, EETimes
5/4/2011 1:22 PM EDT
SAN FRANCISCO - As expected, Intel Corp. Wednesday (May 4) rolled out its 22-nm process—with a twist.
The chip giant introduced the process, based on its long-awaited 3-D transistor design, dubbed tri-gate. First disclosed by Intel in 2002, the tri-gate transistor will form the basis of its 22-nm node. Intel also demonstrated the world's first 22-nm microprocessor, codenamed Ivy Bridge.
Ivy Bridge-based Core family processors will be the first high-volume chips to use tri-gate transistors. Ivy Bridge is slated for high-volume production readiness by the end of this year.
But missing from the announcement was a 22-nm mobile processor, which could fend off competitive threats from the ARM camp.
![]() |
E-mail This Article | ![]() |
![]() |
Printer-Friendly Page |
|
Related News
- Intel's 22-nm tri-gate SoC, how low can you leak?
- Tabula Confirms Move to Intel's 22nm Process Featuring 3-D Tri-Gate Transistors
- Intel Custom Foundry Certifies Cadence Implementation and Signoff Tools for 10nm Tri-Gate Process
- Intel Custom Foundry Certifies Mentor Graphics Physical Verification and Circuit Simulation Tools for 10nm Tri-Gate Process
- Intel Custom Foundry Certifies Synopsys Implementation and Signoff Tools for 10-nm Tri-Gate Process
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- Ceva, Inc. Announces First Quarter 2025 Financial Results
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design